Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poor growth in medical sales for Beiersdorf:

This article was originally published in Clinica

Executive Summary

Sales at the medical division of Beiersdorf (Germany) grew only 0.6% to DM 878 million ($593 million) in the nine months ended September 30th, 1995, compared with last year. Total turnover at Beiersdorf rose 3.2% to DM 4,077 million. At constant exchange rates sales growth would have been over 7% but the strength of the DM pushed this figure down. Domestic sales rose 7.2% to DM 1,535 million and exports increased 0.9% to DM 2,541 million. In the first nine months profits grew slightly faster than turnover. The company forecasts stronger full-year turnover growth than in the first nine months. Full-year profits are also predicted to rise at a greater rate than turnover.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel